| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PF-543 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.02 |
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | -0.14 | 0.02 |
| mRNA | TGX221 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.02 |
| mRNA | purmorphamine | CTRPv2 | pan-cancer | AAC | -0.1 | 0.02 |
| mRNA | azacitidine | CTRPv2 | pan-cancer | AAC | -0.1 | 0.02 |
| mRNA | KPT185 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.02 |
| mRNA | BRD-K86535717 | CTRPv2 | pan-cancer | AAC | 0.19 | 0.02 |
| mRNA | tretinoin:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.094 | 0.02 |
| mRNA | CGP-082996 | GDSC1000 | pan-cancer | AAC | 0.17 | 0.02 |
| mRNA | etoposide | GDSC1000 | pan-cancer | AAC | -0.11 | 0.02 |